Arcadia Biosciences (NASDAQ:RKDA) Coverage Initiated by Analysts at StockNews.com

Posted by Faye Duncan on Dec 3rd, 2024

Equities research analysts at StockNews.com initiated coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) in a research report issued to clients and investors on Sunday. The brokerage set a “sell” rating on the basic materials company’s stock.

Separately, HC Wainwright reiterated a “buy” rating and set a $6.00 target price on shares of Arcadia Biosciences in a research report on Wednesday, August 21st.

Read Our Latest Analysis on RKDA

Arcadia Biosciences Trading Down 1.6 %

Shares of RKDA opened at $2.75 on Friday. Arcadia Biosciences has a twelve month low of $1.85 and a twelve month high of $5.34. The firm has a market capitalization of $3.73 million, a P/E ratio of -0.65 and a beta of 1.27. The firm’s 50-day moving average is $3.32 and its two-hundred day moving average is $3.07.

Arcadia Biosciences Company Profile

(Get Free Report)

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.